Exposure of the retina to subthreshold micro- and nanosecond laser at early stages of age-related macular degeneration

Abstract

At the moment, there are no effective methods of treatment for age-related macular degeneration at its early stages. The perspective of treatment for age-related macular degeneration may be a method using subthreshold laser radiation.

In the present review of literature, analysis is represented of using both subthreshold micro- and nanosecond laser radiation on the retina in intermediate AMD stage. Subthreshold diode micro-pulse laser exposure of the retina in AMD has proven to be a safe procedure that allows for the regression of macular drusen.

While some authors noted an improvement in visual functions and a decrease in the probability of developing choroidal neovascularization with such treatment, multicenter trials have not yet confirmed the effectiveness of micro-pulse therapy as a method to prevent the neovascular AMD development.

Subthreshold nanosecond laser impact on the retina is safe for the structures of the eye fundus, theoretically more selective stimulates the natural biological and regenerative potential in the pigment epithelium and neuroepithelium due to remodeling of extracellular matrix, restores the thickness of the Bruch’s membrane and metabolism between external retinal layers and choriocapillaris.

Encouraging results have been achieved from the use of nanopulse therapy as a method of preventing the development of advanced stage AMD in the absence of reticular pseudodrusen, however, it seems premature to recommend this technology for widespread clinical use - further research is needed.

The prospects of invading in wide clinical practice of subthreshold nanosecond laser impact on the intermediate stage of AMD on the basis of the obtained clinical research results are encouraging (regression of drusen, preventing of AMD progression in absence of reticular pseudodrusen), but there is currently no evidence base. It is required to conduct further researches.

Keywords

age-related macular degeneration / subthreshold micro-pulse exposure / subthreshold nanosecond laser exposure / reticular pseudodrusen

References

[1] Congdon N, O’Colmain B, Klaver CC, et al. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4): 477–485. DOI: 10.1001/archopht.122.4.477

[2] Congdon N., O’Colmain B., Klaver C.C., et al. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States // Arch Ophthalmol. 2004. Vol. 122, No. 4. P. 477–485. DOI: 10.1001/archopht.122.4.477

[3] Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet. 2012;379(9827):1728–1738. DOI: 10.1016/S0140-6736(12)60282-7

[4] Lim L.S., Mitchell P., Seddon J.M., et al. Age-related macular degeneration // Lancet. 2012. Vol. 379, No. 9827. P. 1728–1738. DOI: 10.1016/S0140-6736(12)60282-7

[5] Stahl A. The diagnosis and treatment of age-related macular degeneration. Dtsch Arztebl Int. 2020;117(29–30):513–520. DOI: 10.3238/arztebl.2020.0513

[6] Stahl A. The diagnosis and treatment of age-related macular degeneration // Dtsch Arztebl Int. 2020. Vol. 117, No. 29–30. P. 513–520. DOI: 10.3238/arztebl.2020.0513

[7] Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014;2(2):106–116. DOI: 10.1016/S2214-109X(13)70145-1

[8] Wong W.L., Su X., Li X., et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis // Lancet Global Health. 2014. Vol. 2, No. 2. P. 106–116. DOI: 10.1016/S2214-109X(13)70145-1

[9] Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973;90(3):206–217. DOI: 10.1001/archopht.1973.01000050208006

[10] Gass J.D. Drusen and disciform macular detachment and degeneration // Arch Ophthalmol. 1973. Vol. 90, No. 3. P. 206–217. DOI: 10.1001/archopht.1973.01000050208006

[11] Frennesson C, Nilsson SEG. Prophylactic laser treatment in early age-related maculopathy reduced the incidence of exudative complications. Br J Ophthalmol. 1998;82(10):1169–1174. DOI: 10.1136/bjo.82.10.1169

[12] Frennesson C., Nilsson S.E.G. Prophylactic laser treatment in early age-related maculopathy reduced the incidence of exudative complications // Br J Ophthalmol. 1998. Vol. 82, No. 10. P. 1169–1174. DOI: 10.1136/bjo.82.10.1169

[13] Duvall J, Tso MO. Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. Arch Ophthalmol. 1985;103(50):694–703. DOI: 10.1001/archopht.1985.0105005008602

[14] Duvall J., Tso M.O. Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study // Arch Ophthalmol. 1985. Vol. 103, No. 5. P. 694–703. DOI: 10.1001/archopht.1985.0105005008602

[15] Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Ophthalmology. 1998;105(8): 11–23. DOI: 10.1016/S0161-6420(98)98014-9

[16] Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial // Ophthalmology. 1998. Vol. 105, No. 8. P. 11–23. DOI: 10.1016/S0161-6420(98)98014-9

[17] The Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology. 2003;110(5):971–978. DOI: 10.1016/S0161-6420(03)00098-8

[18] The Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial // Ophthalmology. 2003. Vol. 110, No. 5. P. 971–978. DOI: 10.1016/S0161-6420(03)00098-8

[19] Friberg TR, Brennen PM, Freeman WR, et al. Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients. Ophthalmic Surgery, Lasers and Imaging Retina. 2009;40(6):530–538. DOI: 10.3928/15428877-20091030-01

[20] Friberg T.R., Brennen P.M., Freeman W.R., et al. Prophylactic treatment of age-related macular degeneration report number 2: 810-nanometer laser to eyes with drusen: bilaterally eligible patients // Ophthalmic Surgery, Lasers and Imaging Retina. 2009. Vol. 40, No. 6. P. 530–538. DOI: 10.3928/15428877-20091030-01

[21] Friberg TR, Musch DC, Lim JI, et al. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients. Ophthalmology. 2006;113(4):622–621. DOI: 10.1016/j.ophtha.2005.10.066

[22] Friberg T.R., Musch D.C., Lim J.I., et al. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients // Ophthalmology. 2006. Vol. 113, No. 4. P. 622–621. DOI: 10.1016/j.ophtha.2005.10.066

[23] Virgili G, Michelessi M, Parodi MB, et al. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst Rev. 2015;10(10): CD006537. DOI: 10.1002/14651858.CD006537.pub3

[24] Virgili G., Michelessi M., Parodi M.B., et al. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration // Cochrane Database Syst Rev. 2015. Vol. 10, No. 10. ID CD006537. DOI: 10.1002/14651858.CD006537.pub3

[25] Mojana F, Brar M, Cheng L, et al. Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen. Retina. 2011;31(2):235–242. DOI: 10.1097/IAE.0b013e3181ec80ad

[26] Mojana F., Brar M., Cheng L., et al. Long-term SD-OCT/SLO imaging of neuroretina and retinal pigment epithelium after subthreshold infrared laser treatment of drusen // Retina. 2011. Vol. 31, No. 2. P. 235–242. DOI: 10.1097/IAE.0b013e3181ec80ad

[27] Cohn AC, Wu Z, Jobling AI, et al. Subthreshold nano-second laser treatment and age-related macular degeneration. J Clin Med. 2021;10(3):484. DOI: 10.3390/jcm10030484

[28] Cohn A.C., Wu Z., Jobling A.I., et al. Subthreshold nano-second laser treatment and age-related macular degeneration // J Clin Med. 2021. Vol. 10, No. 3. ID484. DOI: 10.3390/jcm10030484

[29] Eng VA, Wood EH, Boddu S, et al. Preventing progression in nonexudative age-related macular degeneration with subthreshold laser therapy: a systematic review. Ophthalmic Surg Lasers Imaging Retina. 2019;50(3):61–70. DOI: 10.3928/23258160-20190301-13

[30] Eng V.A., Wood E.H., Boddu S., et al. Preventing progression in nonexudative age-related macular degeneration with subthreshold laser therapy: a systematic review // Ophthalmic Surg Lasers Imaging Retina. 2019. Vol. 50, No. 3. P. 61–70. DOI: 10.3928/23258160-20190301-13

[31] Zheltov GI, Romanov GS, Romanov OG, Ivanova EV. Selektivnoe deistvie lazernykh impulsov na retinalnyi pigmentnyi ehpitelii. Fizicheskie osnovy. Novoe v oftalmologii. 2012;(3):37–43. (In Russ.)

[32] Желтов Г.И., Романов Г.С., Романов О.Г., Иванова Е.В. Селективное действие лазерных импульсов на ретинальный пигментный эпителий. Физические основы // Новое в офтальмологии. 2012. № 3. С. 37–43.

[33] Berger JW. Thermal modelling of micropulsed diode laser retinal photocoagulation. Lasers Surg Med. 1997;20(4):409–415. DOI: 10.1002/(sici)1096-9101(1997)20:4<409: aid-lsm6>3.0.co;2-u

[34] Berger J.W. Thermal modelling of micropulsed diode laser retinal photocoagulation // Lasers Surg Med. 1997. Vol. 20, No. 4. P. 409–415. DOI: 10.1002/(sici)1096-9101(1997)20:4<409: aid-lsm6>3.0.co;2-u

[35] Yu D-Y, Cringle SJ, Su E, et al. Laser-induced changes in intraretinal oxygen distribution in pigmented rabbits. Investig Ophthalmol Vis Sci. 2005;46(3):988–999. DOI: 10.1167/iovs.04-0767

[36] Yu D.-Y., Cringle S.J., Su E., et al. Laser-induced changes in intraretinal oxygen distribution in pigmented rabbits // Investig Ophthalmol Vis Sci. 2005. Vol. 46, No. 3. P. 988–999. DOI: 10.1167/iovs.04-0767

[37] Framme C, Alt C, Schnell S, et al. Selective targeting of the retinal pigment epithelium in rabbit eyes with a scanning laser beam. Investig Ophthalmol Vis Sci. 2007;48(4):1782–1792. DOI: 10.1167/iovs.06-0797

[38] Framme C., Alt C., Schnell S., et al. Selective targeting of the retinal pigment epithelium in rabbit eyes with a scanning laser beam // Investig Ophthalmol Vis Sci. 2007. Vol. 48, No. 4. P. 1782–1792. DOI: 10.1167/iovs.06-0797

[39] Framme C, Schuele G, Roider J, et al. Threshold determinations for selective retinal pigment epithelium damage with repetitive pulsed microsecond laser systems in rabbits. Ophthalmic Surg Lasers. 2002;33(5):400–409. DOI: 10.3928/1542-8877-20020901-10

[40] Framme C., Schuele G., Roider J., et al. Threshold determinations for selective retinal pigment epithelium damage with repetitive pulsed microsecond laser systems in rabbits // Ophthalmic Surg Lasers. 2002. Vol. 33, No. 5. P. 400–409. DOI: 10.3928/1542-8877-20020901-10

[41] Hayes JR, Wolbarsht ML. Thermal model for retinal damage induced by pulsed laser. Aerospace Medicine. 1968;39(5):474–480.

[42] Hayes J.R., Wolbarsht M.L. Thermal model for retinal damage induced by pulsed laser // Aerospace Medicine. 1968. Vol. 39, No. 5. P. 474–480.

[43] Wang J, Quan Y, Dalal R, Palanker D. Comparison of continuous-wave and micropulse modulation in retinal laser therapy. Investig Ophthalmol Vis Sci. 2017;58(11):4722–4732. DOI: 10.1167/iovs.17-21610

[44] Wang J., Quan Y., Dalal R., Palanker D. Comparison of continuous-wave and micropulse modulation in retinal laser therapy // Investig Ophthalmol Vis Sci. 2017. Vol. 58, No. 11. P. 4722–4732. DOI: 10.1167/iovs.17-21610

[45] Luttrull JK, Sinclair SH, Elmann S, Glaser BM. Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD. PLoS One. 2018;13(8):0202097. DOI: 10.1371/journal.pone.0202097

[46] Luttrull J.K., Sinclair S.H., Elmann S., Glaser B.M. Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD // PLoS One. 2018. Vol. 13, No. 8. ID 0202097. DOI: 10.1371/journal.pone.0202097

[47] Luttrull JK, Sinclair SH, Elmann S, et al. Slowed progression of age-related geographic atrophy following subthreshold laser. Clin Ophthalmol (Auckland, N.Z.). 2020;14:2983–2993. DOI: 10.2147/OPTH.S268322

[48] Luttrull J.K., Sinclair S.H., Elmann S., et al. Slowed progression of age-related geographic atrophy following subthreshold laser // Clin Ophthalmol (Auckland, N.Z.). 2020. Vol. 14. P. 2983–2993. DOI: 10.2147/OPTH.S268322

[49] Patent RUS № 2017110294/ 29.03.2017. Malinovskaya MA, Stanishevskaya OM. Sposob lecheniya makulyarnykh druz pri vozrastnoi makulodistrofii. (In Russ.)

[50] Патент на РФ на изобретение № 2017110294/ 29.03.2017. Малиновская М.А., Станишевская О.М. Способ лечения макулярных друз при возрастной макулодистрофии.

[51] Patent RUS № 2696927/ 07.08.2019. Dalalishvili MA, Takhchidi KhP, Kachalina GF, et al. Sposob lecheniya retikulyarnykh psevdodruz mikroimpul’snym lazernym vozdeistviem. (In Russ.)

[52] Патент РФ на изобретение № 2696927/ 07.08.2019. Далалишвили М.А., Тахчиди Х.П., Качалина Г.Ф., и др. Способ лечения ретикулярных псевдодруз микроимпульсным лазерным воздействием.

[53] Querques G, Sacconi R, Gelormini F, et al. Subthreshold laser treatment for reticular pseudodrusen secondary to age-related macular degeneration. Sci Rep. 2021;11(1):2193. DOI: 10.1038/s41598-021-81810-7

[54] Querques G., Sacconi R., Gelormini F., et al. Subthreshold laser treatment for reticular pseudodrusen secondary to age-related macular degeneration // Sci Rep. 2021. Vol. 11, No. 1. ID 2193. DOI: 10.1038/s41598-021-81810-7

[55] Roider J, Brinkmann R, Wirbelauer C, et al. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol. 2000;84(1):40–47. DOI: 10.1136/bjo.84.1.40

[56] Roider J., Brinkmann R., Wirbelauer C., et al. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study // Br J Ophthalmol. 2000. Vol. 84, No. 1. P. 40–47. DOI: 10.1136/bjo.84.1.40

[57] Zhang JJ, Sun Y, Hussain AA, Marshall J. Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases. Investig Ophthalmol Vis Sci. 2012;53(6):2928–2937. DOI: 10.1167/iovs.11-8585

[58] Zhang J.J., Sun Y., Hussain A.A., Marshall J. Laser-mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases // Investig Ophthalmol Vis Sci. 2012. Vol. 53, No. 6. P. 2928–2937. DOI: 10.1167/iovs.11-8585

[59] Jobling AI, Guymer RH, Vessey KA, et al. Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage. FASEB journal. 2015;29(2):696–710. DOI: 10.1096/fj.14-262444

[60] Jobling A.I., Guymer R.H., Vessey K.A., et al. Nanosecond laser therapy reverses pathologic and molecular changes in age-related macular degeneration without retinal damage // FASEB journal. 2015. Vol. 29, No. 2. P. 696–710. DOI: 10.1096/fj.14-262444

[61] Chidlow G, Shibeeb O, Plunkett M, et al. Glial cell and inflammatory responses to retinal laser treatment: comparison of a conventional photocoagulator and a novel, 3-nanosecond pulse laser. Investig Ophthalmol Vis Sci. 2013;54(3):2319–2332. DOI: 10.1167/iovs.12-11204

[62] Chidlow G., Shibeeb O., Plunkett M., et al. Glial cell and inflammatory responses to retinal laser treatment: comparison of a conventional photocoagulator and a novel, 3-nanosecond pulse laser // Investig Ophthalmol Vis Sci. 2013. Vol. 54, No. 3. P. 2319–2332. DOI: 10.1167/iovs.12-11204

[63] Vessey KA, Ho T, Jobling AI, et al. nanosecond laser treatment for age-related macular degeneration does not induce focal vision loss or new vessel growth in the retina. Investig Ophthalmol Vis Sci. 2018;59(2):731–745. DOI: 10.1167/iovs.17-23098

[64] Vessey K.A., Ho T., Jobling A.I., et al. Nanosecond laser treatment for age-related macular degeneration does not induce focal vision loss or new vessel growth in the retina // Investig Ophthalmol Vis Sci. 2018. Vol. 59, No. 2. P. 731–745. DOI: 10.1167/iovs.17-23098

[65] Chichan H, Maus M, Heindl LM. subthreshold nanosecond laser, from trials to real-life clinical practice: A cohort study. Clin Ophthalmol (Auckland, N.Z.). 2021;15:1887–1895. DOI: 10.2147/OPTH.S307671

[66] Chichan H., Maus M., Heindl L.M. Subthreshold nanosecond laser, from trials to real-life clinical practice: A cohort study // Clin Ophthalmol (Auckland, N.Z.). 2021. Vol. 15. P. 1887–1895. DOI: 10.2147/OPTH.S307671

[67] Gunawan JR, Thiele SH, Isselmann B, et al. Effect of subthreshold nanosecond laser on retinal structure and function in intermediate age-related macular degeneration. Clin Exp Ophthalmol. 2022;50(1):31–39. DOI: 10.1111/ceo.14018

[68] Gunawan J.R., Thiele S.H., Isselmann B., et al. Effect of subthreshold nanosecond laser on retinal structure and function in intermediate age-related macular degeneration // Clin Exp Ophthalmol. 2022. Vol. 50, No. 1. P. 31–39. DOI: 10.1111/ceo.14018

[69] Hanna V, Oakley J, Russakoff D, Choudhry N. Effects of subthreshold nanosecond laser therapy in age-related macular degeneration using artificial intelligence (STAR-AI Study). PLoS One. 2021;4: e0250609. DOI: 10.1371/journal.pone.0250609

[70] Hanna V., Oakley J., Russakoff D., Choudhry N. Effects of subthreshold nanosecond laser therapy in age-related macular degeneration using artificial intelligence (STAR-AI Study) // PLoS One. 2021. Vol. 4. ID e0250609. DOI: 10.1371/journal.pone.0250609

[71] Smith TR. Sub-threshold nanosecond laser (SNL) treatment in intermediate AMD (IAMD). Ann Eye Sci. 2019;4:2. DOI: 10.21037/aes.2018.12.04

[72] Smith T.R. Sub-threshold nanosecond laser (SNL) treatment in intermediate AMD (IAMD) // Ann Eye Sci. 2019. Vol. 4. P. 2. DOI: 10.21037/aes.2018.12.04

[73] Wu Z, Luu CD, Hodgson LAB, et al. Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: A LEAD study report. Ophthalmology. Retina. 2019;3(12):1026–1034. DOI: 10.1016/j.oret.2019.07.008

[74] Wu Z., Luu C.D., Hodgson L.A.B., et al. Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: A LEAD study report // Ophthalmology. Retina. 2019. Vol. 3, No. 12. P. 1026–1034. DOI: 10.1016/j.oret.2019.07.008

[75] Guymer RH, Wu Z, Hodgson LAB, et al. Subthreshold nanosecond laser intervention in age-related macular degeneration: The LEAD randomized controlled clinical trial. Randomized Controlled Trial Ophthalmology. 2019;126(6):829–838. DOI: 10.1016/j.ophtha.2018.09.015

[76] Guymer R.H., Wu Z., Hodgson L.A.B., et al. Subthreshold nanosecond laser intervention in age-related macular degeneration: The LEAD randomized controlled clinical trial // Randomized Controlled Trial Ophthalmology. 2019. Vol. 126, No. 6. P. 829–838. DOI: 10.1016/j.ophtha.2018.09.015

[77] Guymer RH, Chen FK, Hodgson LAB, et al. Subthreshold nanosecond laser in age-related macular degeneration: observational extension study of the LEAD clinical trial. Ophthalmol Retina. 2021;5(12):1196–1203. DOI: 10.1016/j.oret.2021.02.015

[78] Guymer R.H., Chen F.K., Hodgson L.A.B., et al. Subthreshold nanosecond laser in age-related macular degeneration: observational extension study of the LEAD clinical trial // Ophthalmol Retina. 2021. Vol. 5, No. 12. P. 1196–1203. DOI: 10.1016/j.oret.2021.02.015

[79] Rosenfeld PJ, Feuer WJ. Warning: do not treat intermediate AMD with laser therapy. Ophthalmology. 2019;126(6):839–840. DOI: 10.1016/j.ophtha.2018.12.016

[80] Rosenfeld P.J., Feuer W.J. Warning: Do Not Treat intermediate AMD with laser therapy // Ophthalmology. 2019. Vol. 126, No. 6. P. 839–840. DOI: 10.1016/j.ophtha.2018.12.016

RIGHTS & PERMISSIONS

Gavrilova N.A., Gadzhieva N.S., Subbota E.A.